{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:01:34Z","timestamp":1794049294495,"version":"4.8.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>It is unclear whether confounding accounts for the increased risk of preterm birth and small for gestational age (SGA) birth in opioid analgesic exposed pregnancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using universal coverage health data for Ontario, we assembled a cohort of mother\u2013infant pairs without opioid use disorder (627,172 pregnancies and 509,522 women). We estimated risk ratios (RRs) between opioid analgesics and preterm birth, SGA birth, and stillbirth; neonatal abstinence syndrome was a secondary outcome. We used high-dimensional propensity scores and sensitivity analyses for confounding adjustment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>4% of pairs were exposed, mainly to codeine (2%), morphine (1%), and oxycodone (1%). Compared with unexposed, the adjusted risk of preterm birth was higher with any (1.3, 95% confidence interval [CI] = 1.2, 1.3), first- (RR: 1.2, 95% CI = 1.2, 1.3), and second-trimester (RR: 1.3, 95% CI = 1.2, 1.4) opioid analgesic exposure. Preterm birth risk was higher for first- and second-trimester codeine, morphine, and oxycodone exposure, and for third-trimester morphine. There was a small increase in SGA with first-trimester exposure to any opioid analgesic or to codeine. Exposed pregnancies had an elevated stillbirth risk with any (RR: 1.6, 95% CI = 1.4, 1.8), first- and second-trimester exposure. Few infants had neonatal abstinence syndrome (N = 143); the risk was higher in exposed (RR: 3.6, 95% CI = 2.1, 6.0). In sensitivity analyses of unmeasured confounding, an elevated risk in exposed pregnancies persisted for preterm birth but not SGA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Opioid analgesic-exposed pregnancies had a small increased risk of preterm birth and possibly stillbirth after accounting for confounding by indication and sociodemographic factors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ede.0000000000001328","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:08:19Z","timestamp":1614384499000},"page":"448-456","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":47,"title":["Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes"],"prefix":"10.1097","volume":"32","author":[{"given":"Susan B.","family":"Brogly","sequence":"first","affiliation":[{"name":"Department of Surgery, Queen\u2019s University, Kingston, Ontario, Canada"},{"name":"ICES"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Velez","sequence":"additional","affiliation":[{"name":"ICES"},{"name":"Department of Obstetrics and Gynaecology, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Werler","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Boston University School of Public Health, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[{"name":"ICES"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi","family":"Camden","sequence":"additional","affiliation":[{"name":"ICES"},{"name":"Dalla Lana School of Public Health, University of Toronto"},{"name":"The Hospital for Sick Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Guttmann","sequence":"additional","affiliation":[{"name":"ICES"},{"name":"Dalla Lana School of Public Health, University of Toronto"},{"name":"The Hospital for Sick Children"},{"name":"Leong Centre for Healthy Children, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"R1-20250801","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among Medicaid-enrolled women.","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R2-20250801","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jogc.2016.11.009","article-title":"Infants born to opioid-dependent women in Ontario, 2002-2014.","volume":"39","author":"Brogly","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R3-20250801","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11592700-000000000-00000","article-title":"The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn.","volume":"13","author":"Knoppert","year":"2011","journal-title":"Paediatr Drugs"},{"key":"R4-20250801","first-page":"37","article-title":"Opioid prescription claims among women of reproductive age","volume":"64","author":"Ailes","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20250801","doi-asserted-by":"crossref","first-page":"404.e1","DOI":"10.1016\/j.ajog.2014.03.054","article-title":"Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant Study.","volume":"211","author":"Marsh","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20250801","doi-asserted-by":"crossref","first-page":"314.e1","DOI":"10.1016\/j.ajog.2010.12.039","article-title":"Maternal treatment with opioid analgesics and risk for birth defects.","volume":"204","author":"Broussard","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20250801","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/1552-6909.12487","article-title":"Safe management of chronic pain in pregnancy in an era of opioid misuse and abuse.","volume":"43","author":"Pritham","year":"2014","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R8-20250801","first-page":"431","article-title":"Is periconceptional opioid use safe?","volume":"61","author":"Chan","year":"2015","journal-title":"Can Fam Physician"},{"key":"R9-20250801","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature.","volume":"4","author":"Yazdy","year":"2015","journal-title":"J Pediatr Genet"},{"key":"R10-20250801","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy.","volume":"6","author":"K\u00e4ll\u00e9n","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"R11-20250801","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","article-title":"Effects of codeine on pregnancy outcome: results from a large population-based cohort study.","volume":"67","author":"Nezvalov\u00e1-Henriksen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"R12-20250801","doi-asserted-by":"crossref","first-page":"e208256","DOI":"10.1001\/jamanetworkopen.2020.8256","article-title":"Association of maternal opioid use in pregnancy with adverse perinatal outcomes in Ontario, Canada, from 2012 to 2018.","volume":"3","author":"Corsi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R13-20250801","doi-asserted-by":"crossref","first-page":"e1002980","DOI":"10.1371\/journal.pmed.1002980","article-title":"Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: a population-based study.","volume":"16","author":"Sujan","year":"2019","journal-title":"PLoS Med"},{"key":"R14-20250801","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/651232","article-title":"Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.","volume":"201","author":"Patel","year":"2010","journal-title":"J Infect Dis"},{"key":"R15-20250801","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R16-20250801","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/aje\/kwx341","article-title":"Neonatal outcomes in a Medicaid population with opioid dependence.","volume":"187","author":"Brogly","year":"2018","journal-title":"Am J Epidemiol"},{"key":"R17-20250801","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases.","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R18-20250801","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.9778\/cmajo.20160092","article-title":"Estimated reductions in provider-initiated preterm births and hospital length of stay under a universal acetylsalicylic acid prophylaxis strategy: a retrospective cohort study.","volume":"5","author":"Ray","year":"2017","journal-title":"CMAJ Open"},{"key":"R19-20250801","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age.","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"R20-20250801","doi-asserted-by":"crossref","first-page":"F26","DOI":"10.1136\/archdischild-2015-308948","article-title":"Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada.","volume":"101","author":"Davies","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R21-20250801","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"R22-20250801","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/jama.2017.3415","article-title":"Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children.","volume":"317","author":"Brown","year":"2017","journal-title":"JAMA"},{"key":"R23-20250801","doi-asserted-by":"crossref","first-page":"h2298","DOI":"10.1136\/bmj.h2298","article-title":"Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.","volume":"350","author":"Vigod","year":"2015","journal-title":"BMJ"},{"key":"R24-20250801","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"R25-20250801","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"R26-20250801","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/bdra.23271","article-title":"Immortal time bias in observational studies of drug effects in pregnancy.","volume":"100","author":"Matok","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R27-20250801","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.EDE.0000071419.41011.cf","article-title":"Semi-automated sensitivity analysis to assess systematic errors in observational data.","volume":"14","author":"Lash","year":"2003","journal-title":"Epidemiology"},{"key":"R28-20250801","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies.","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiology"},{"key":"R29-20250801","doi-asserted-by":"crossref","first-page":"e1910734","DOI":"10.1001\/jamanetworkopen.2019.10734","article-title":"Opioid prescribing after surgery in the United States, Canada, and Sweden.","volume":"2","author":"Ladha","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R30-20250801","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00228-011-1049-9","article-title":"Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.","volume":"67","author":"Lacroix","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"R31-20250801","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes.","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"R32-20250801","doi-asserted-by":"crossref","first-page":"906723","DOI":"10.1155\/2014\/906723","article-title":"Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States.","volume":"2014","author":"Whiteman","year":"2014","journal-title":"J Pregnancy"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:06:14Z","timestamp":1754060774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EDE.0000000000001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000001328","relation":{},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,19]]}}}